The core generic pharma business of Strides is led by IP-driven product licensing and marketing and distribution partnerships across the globe. We have leveraged our expertise in niche, difficult-to-develop and manufacture products to emerge as a preferred provider of solutions to global pharma majors. Strides has created an exhaustive pipeline of generics across varied formats and domains including oral dosage forms and topicals. We are one among the leading players worldwide in soft gel capsules.